Julius M. Wilder, Ph.D. - Publications

Affiliations: 
2007 Duke University, Durham, NC 
Area:
Demography, Public and Social Welfare, Ethnic and Racial Studies, Black Studies

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Henson JB, Wilder JM, Kappus MR, Barbas AS, Moylan CA, Niedzwiecki D, Muir AJ, Berg CL, Patel YA. Transplant Outcomes in Older Patients with Nonalcoholic Steatohepatitis Compared to Alcohol-Related Liver Disease and Hepatitis C. Transplantation. PMID 32150036 DOI: 10.1097/Tp.0000000000003219  0.422
2019 Spiritos Z, Salvador S, Mosquera D, Wilder J. Acute Intermittent Porphyria: Current Perspectives And Case Presentation. Therapeutics and Clinical Risk Management. 15: 1443-1451. PMID 31908464 DOI: 10.2147/Tcrm.S180161  0.356
2019 Proeschold-Bell RJ, Evon DM, Yao J, Niedzwiecki D, Makarushka C, Keefe KA, Patkar AA, Mannelli P, Garbutt JC, Wong JB, Wilder JM, Datta SK, Hodge T, Naggie S, Fried MW, et al. A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection. Hepatology (Baltimore, Md.). PMID 31803945 DOI: 10.1002/Hep.31058  0.323
2019 Wilder J, Choi SS, Moylan CA. Evaluation for Fibrosis After Cure of Hepatitis C-Reply. Jama. 321: 1535. PMID 30990548 DOI: 10.1001/Jama.2019.0873  0.407
2019 Mosquera DM, Wilder J, Ellis A, Naggie S. 301. Risk of Virologic Failure with Antiretroviral Switches in HIV/HCV Co-infections Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.2506  0.306
2018 Wilder J, Choi SS, Moylan CA. Vibration-Controlled Transient Elastography for Diagnosing Cirrhosis and Staging Hepatic Fibrosis. Jama. PMID 30383175 DOI: 10.1001/Jama.2018.13073  0.369
2018 Patel YA, Henson JB, Wilder JM, Zheng J, Chow SC, Berg CL, Knechtle SJ, Muir AJ. The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. Clinical Transplantation. e13388. PMID 30136315 DOI: 10.1111/Ctr.13388  0.338
2018 Proeschold-Bell RJ, Evon DM, Makarushka C, Wong JB, Datta SK, Yao J, Patkar AA, Mannelli P, Hodge T, Naggie S, Wilder JM, Fried MW, Niedzwiecki D, Muir AJ. The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial. Contemporary Clinical Trials. PMID 30006024 DOI: 10.1016/J.Cct.2018.07.003  0.391
2018 Clement ME, Collins LF, Wilder JM, Mugavero M, Barker T, Naggie S. Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure. Infectious Disease Clinics of North America. 32: 407-423. PMID 29778263 DOI: 10.1016/J.Idc.2018.02.005  0.374
2018 Wilder JM, Muir A. Direct Acting Antivirals for the Treatment of Hepatitis C in Ethnic Minority Populations. Expert Opinion On Pharmacotherapy. PMID 29488438 DOI: 10.1080/14656566.2018.1446945  0.373
2018 Collins LF, Chan A, Zheng J, Chow SC, Wilder JM, Muir AJ, Naggie S. Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection. Open Forum Infectious Diseases. 5: ofx264. PMID 29308413 DOI: 10.1093/Ofid/Ofx264  0.372
2018 Dola T, Hughes B, Brady CW, Wilder JM, Muir AJ. Mo1429 - Hepatitis C Infection Knowledge and Awareness Among Women of Childbearing Age Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)33977-5  0.327
2018 Ramchal TD, Brown C, Wilder JM. Sa1444 - Navigating the Intersection of End Stage Liver Disease and Palliative Care: Defining Symptoms and Experiences of Liver Patients a the End of Life Gastroenterology. 154. DOI: 10.1016/S0016-5085(18)33711-9  0.357
2017 Henson JB, Patel YA, Wilder JM, Zheng J, Chow SC, King LY, Muir AJ. Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis. Digestive Diseases and Sciences. PMID 28391417 DOI: 10.1007/S10620-017-4559-1  0.344
2016 Wilder JM, Oloruntoba OO, Muir AJ, Moylan CA. Role of patient factors, preferences and distrust in health care and access to liver transplantation and organ donation. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 27027394 DOI: 10.1002/Lt.24452  0.357
2016 Wilder J, Saraswathula A, Hasselblad V, Muir A. A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial Enrollment. Journal of the National Medical Association. 108: 24-9. PMID 26928485 DOI: 10.1016/J.Jnma.2015.12.004  0.352
2016 Wilder J, Henson J, Patel Y, Zheng J, Chow S, Muir A. Racial Differences in Phenotype and Outcome Among Patients with Primary Sclerosing Cholangitis Listed for Liver Transplant: 2016 ACG Fellows-In-Training Award (Liver Category): 758 The American Journal of Gastroenterology. 111. DOI: 10.14309/00000434-201610001-00758  0.399
2015 Wilder JM, Muir AJ. Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes. Therapeutic Advances in Chronic Disease. 6: 314-27. PMID 26568808 DOI: 10.1177/2040622315603642  0.466
2015 Wilder JM, Jeffers LJ, Ravendhran N, Shiffman ML, Poulos J, Sulkowski MS, Gitlin N, Workowski K, Zhu Y, Yang JC, Pang PS, McHutchison JG, Muir AJ, Howell C, Kowdley K, et al. Safety and Efficacy of Ledipasvir-Sofosbuvir in African Americans with Hepatitis C Virus Infection: A Retrospective Analysis of Phase 3 Data. Hepatology (Baltimore, Md.). PMID 26547499 DOI: 10.1002/Hep.28334  0.366
2015 Wilder J, Chang S, Cardona D, Patel K, Brady C. Acute liver failure in the setting of herpes simplex virus and coexistent acute fatty liver of pregnancy Case Reports in Clinical Pathology. 2: 89. DOI: 10.5430/Crcp.V2N2P89  0.395
2015 Matta B, Wilder J, Lee T, Patel K. Predictive Performance of FIB 4 and APRI for Liver Fibrosis Assessment in Hepatitis C in Comparison to Transient Elastography: 2118 The American Journal of Gastroenterology. 110. DOI: 10.14309/00000434-201510001-02118  0.428
2014 Wilder J, Patel K. The clinical utility of FibroScan(®) as a noninvasive diagnostic test for liver disease. Medical Devices (Auckland, N.Z.). 7: 107-14. PMID 24833926 DOI: 10.2147/Mder.S46943  0.38
2014 Wilder JM, Patel K. A Review of the Natural History of Chronic Hepatitis C Infection North American Journal of Medicine & Science. 7: 1. DOI: 10.7156/Najms.2014.0701001  0.431
2014 Patel K, Wilder J. Fibroscan Clinical Liver Disease. 4: 97-100. DOI: 10.1002/Cld.407  0.329
Show low-probability matches.